How long can you live with kidney cancer?

Kidney cancer, also known as renal cell carcinoma or renal adenocarcinoma, originates from renal tubular epithelial cells and can occur in any part of the renal parenchyma, but is most common in the upper and lower kidneys, with a few invading the entire kidney. The left and right kidneys have equal chances of developing the disease, with bilateral lesions accounting for 1% to 2%. The incidence of kidney cancer is relatively high among cancers. How long can a person with kidney cancer live is a question of great concern to many kidney cancer patients and their families. So how long can a person with kidney cancer live?

The question of how long you can live with kidney cancer is actually very difficult to answer. The treatment of kidney cancer is a systematic treatment process involving many factors. In general, how long you can live with kidney cancer, in other words, how long the survival of kidney cancer patients is depends mainly on whether the treatment method is appropriate and the patient's physical fitness. In addition, kidney cancer patients or their families should learn more about kidney cancer treatment knowledge and communicate more with the attending physician, which will help extend the survival of kidney cancer patients.

Whether the treatment of kidney cancer is appropriate is the most important factor affecting how long patients with metastatic kidney cancer can live. As far as the treatment of advanced kidney cancer is concerned, the possibility of surgical resection is very low. Clinically, the treatment methods for kidney cancer patients mainly include radiotherapy, chemotherapy, traditional Chinese medicine treatment and immunotherapy. The above methods have their own advantages in the treatment of kidney cancer patients, but they also have certain disadvantages. Kidney cancer is not very sensitive to radiotherapy, but for kidney cancer patients, radiotherapy can alleviate local pain, hematuria and relieve toxic symptoms to a certain extent. However, since radiotherapy can also harm normal cells, radiotherapy should be used with caution for patients with advanced kidney cancer who have very weak physical functions. Kidney cancer is also insensitive to chemotherapy. Cyclophosphamide, 6-mercaptopurine, vinblastine, dactinomycin and cyclohexylnitrosourea have some therapeutic value. If combined with radiotherapy, the effect is better than chemotherapy or radiotherapy alone.

Biological immunotherapy can expand the effects of cellular and antibody immune responses through immune-active cells and enhance the host's anti-tumor ability. Its efficacy has been increasingly recognized. Entering the 21st century, the Biological Diagnosis and Treatment Center of Shandong Armed Police Corps Hospital has developed modern science and technology and has achieved remarkable results in the clinic by using biotechnology to treat cancer, prevent postoperative recurrence and metastasis of cancer patients, and improve the efficacy of advanced patients. This is "DC+CIK tumor biological therapy".

DC+CIK biological therapy is the fourth type of cancer treatment method developed after surgery, radiotherapy and chemotherapy. It uses and stimulates the body's immune response to fight, inhibit and kill cancer cells. Different from traditional treatment methods, biological therapy mainly mobilizes the body's natural anti-cancer ability and restores the balance of the body's internal environment, which is equivalent to "strengthening the body and harmonizing yin and yang" in traditional Chinese medicine. Immunotherapy and gene therapy are both biological therapies, and immunotherapy is currently the most widely used in clinical practice.

The entire treatment process of the "DC+CIK tumor biotherapy" technology is divided into three parts: collection of patient peripheral blood mononuclear cells, in vitro induction and re-infusion.

1. Collect mononuclear cells from the patient's peripheral blood and send them to a specialized GMP laboratory for in vitro culture and induction to obtain mature DC cells with tumor cell recognition ability and more numerous, more active and more lethal CIK cells;

2. The two types of cells are divided into two groups and then infused back into the patient's body like an IV drip, using them to specifically kill tumor cells, which is safe and has no toxic side effects;

3. Activate the human immune mechanism, improve human immunity, and effectively remove the tiny lesions of residual tumor cells in the patient's body, so as to control tumor growth, prevent tumor recurrence, metastasis and deterioration, and achieve the multiple goals of prolonging patient survival and rapidly improving patient quality of life.

Since biotherapy technology uses the body's own immune cells rather than traditional chemicals to kill tumor cells, it is safe and has no toxic side effects and is suitable for the treatment of all stages of cancer.

In addition, the improvement of the patient's physical function is an important factor affecting how long a kidney cancer patient can live. Only with good physical function and strong immunity can one resist the development of cancer and tolerate various drug treatments. Therefore, improving immune function and enhancing resistance to tumors is extremely important for patients with advanced kidney cancer. In terms of diet, avoid eating moldy, scorched food and unclean water, eat less hot food and salted food, do not drink alcohol or smoke; eat foods that can decompose carcinogens - nitrosamines, such as carrots, peas, melons, pumpkins, etc.; pay attention to a low-salt diet and eat light and vitamin-rich foods.

In general, the survival period of kidney cancer patients varies from person to person. Patients should build confidence, understand their own stage of illness, and find the most appropriate treatment. With the continuous improvement of treatment methods, new treatment methods and drugs are increasingly used in the treatment of patients with metastatic kidney cancer, making the survival period of kidney cancer patients significantly higher than before. Patients should not be trapped by the question of how long they can live with kidney cancer and affect their mood for treatment. They should receive regular treatment as soon as possible.

The above is what experts have told us about kidney cancer. Experts suggest: If you have symptoms of a disease, do not delay diagnosis and go to a regular hospital for treatment in time to avoid delaying the disease and causing serious consequences. If you have other questions, please consult our online experts or call for consultation. I wish you health and happiness!

Kidney cancer http://www..com.cn/zhongliu/sa/